ClinChoice Seminar Held Successfully

ClinChoice recently hosted the “ClinChoice Seminar,” which attracted a large number of attendees from various Pharmaceutical companies across Japan. The seminar focused on “Clinical Pharmaceuticals in the Chinese Market, including Regulatory Affairs in China and the APAC Region,” drawing significant interest and receiving highly positive feedback from participants.

One of the highlights was a session titled “China and USA: Challenges and Opportunities for Combined New Drug Development Strategies,” was particularly well-received, with numerous questions and insights from industry professionals underscoring the high level of interest in the Chinese market. During the networking reception, participants engaged directly with ClinChoice’s Global CEO, Jerry Zhen, as well as keynote speaker Dan Zhang, fostering valuable discussions on both Chinese market dynamics and global regulatory considerations.

Additionally, we organized a special cultural heritage tour, providing a relaxing and enriching experience for our participants. Feedback from the post-event survey indicated strong interest in future seminar topics, such as “Chinese Regulatory Affairs and Agency Relations,” “China’s Special Economic Zones,” “Safety Information Regulations,” and “Drug Pricing Systems.”

The success of this seminar was made possible by the support and active participation of all involved. ClinChoice is committed to continuously delivering services and insights that align with the evolving needs of our clients. We remain dedicated to building the trust and confidence of our partners.

Thank you for your continued support. We look forward to further opportunities to work with you.